T. Rowe Price Associates’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-19,756
| Closed | -$431K | – | 2635 |
|
|
2020
Q2 | $431K | Buy |
19,756
+2,726
| +16% | +$59.5K | ﹤0.01% | 2108 |
|
|
2020
Q1 | $394K | Buy |
17,030
+202
| +1% | +$4.67K | ﹤0.01% | 2091 |
|
|
2019
Q4 | $555K | Buy |
16,828
+1,337
| +9% | +$44.1K | ﹤0.01% | 2112 |
|
|
2019
Q3 | $493K | Buy |
15,491
+171
| +1% | +$5.44K | ﹤0.01% | 2102 |
|
|
2019
Q2 | $394K | Sell |
15,320
-228,175
| -94% | -$5.87M | ﹤0.01% | 2202 |
|
|
2019
Q1 | $6.18M | Sell |
243,495
-113,146
| -32% | -$2.87M | ﹤0.01% | 1379 |
|
|
2018
Q4 | $12.1M | Sell |
356,641
-10,593
| -3% | -$360K | ﹤0.01% | 1279 |
|
|
2018
Q3 | $13.1M | Buy |
367,234
+58,885
| +19% | +$2.1M | ﹤0.01% | 1329 |
|
|
2018
Q2 | $10.6M | Buy |
308,349
+39,340
| +15% | +$1.36M | ﹤0.01% | 1334 |
|
|
2018
Q1 | $9.05M | Sell |
269,009
-128,076
| -32% | -$4.31M | ﹤0.01% | 1350 |
|
|
2017
Q4 | $15.2M | Sell |
397,085
-91,401
| -19% | -$3.49M | ﹤0.01% | 1253 |
|
|
2017
Q3 | $18.3M | Buy |
488,486
+27,993
| +6% | +$1.05M | ﹤0.01% | 1201 |
|
|
2017
Q2 | $17.2M | Buy |
460,493
+33,483
| +8% | +$1.25M | ﹤0.01% | 1217 |
|
|
2017
Q1 | $16.8M | Buy |
427,010
+14,080
| +3% | +$553K | ﹤0.01% | 1227 |
|
|
2016
Q4 | $14.4M | Sell |
412,930
-450
| -0.1% | -$15.7K | ﹤0.01% | 1234 |
|
|
2016
Q3 | $16.2M | Buy |
413,380
+37,800
| +10% | +$1.49M | ﹤0.01% | 1199 |
|
|
2016
Q2 | $14.2M | Buy |
375,580
+10,450
| +3% | +$395K | ﹤0.01% | 1208 |
|
|
2016
Q1 | $14M | Buy |
365,130
+21,640
| +6% | +$832K | ﹤0.01% | 1186 |
|
|
2015
Q4 | $16.5M | Buy |
343,490
+64,990
| +23% | +$3.12M | ﹤0.01% | 1147 |
|
|
2015
Q3 | $11M | Buy |
278,500
+93,700
| +51% | +$3.7M | ﹤0.01% | 1288 |
|
|
2015
Q2 | $7.87M | Buy |
+184,800
| New | +$7.87M | ﹤0.01% | 1398 |
|